Market revenue in 2022 | USD 39.8 million |
Market revenue in 2030 | USD 147.0 million |
Growth rate | 17.7% (CAGR from 2022 to 2030) |
Largest segment | Solid-phase synthesis |
Fastest growing segment | PCR-based Enzyme Synthesis |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis |
Key market players worldwide | Genscript Biotech Corp Class H, Brooks Automation, Twist Bioscience Corp, ProteoGenix, Biomatik Corporation, Thermo Fisher Scientific Inc, Integrated DNA Technologies, Origene Technologies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene synthesis market will help companies and investors design strategic landscapes.
Solid-phase synthesis was the largest segment with a revenue share of 35.93% in 2022. Horizon Databook has segmented the South Korea gene synthesis market based on solid-phase synthesis, chip-based synthesis, pcr-based enzyme synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea is one of the emerging markets for gene synthesis in Asia Pacific region. With growing popularity of genetic testing, genomic research, and precision medicine, the South Korean market for gene synthesis is anticipated to witness significant growth over the forecast period.
In November 2018, meeting of Asian Synthetic Biology Association (ASBA) was held in Republic of Korea. It focused on the recent developments in the synthetic biology field. Such conferences are expected to increase awareness and adoption of new gene synthesis tools and technologies in the market.
Furthermore, in April 2018, Twist Bioscience Corporation expanded its presence in South Korea with strategic distribution agreements with a local company. DNA Link Inc.’s subsidiary—LnCBio Inc.—was selected as the distributor for Twist Bioscience’s synthetic DNA products.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea gene synthesis market, including forecasts for subscribers. This country databook contains high-level insights into South Korea gene synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account